A NAD+ 1000mg & Retatrutide: The UK Advance in Metabolic Wellbeing
Emerging data from the UK are generating considerable excitement surrounding the potential pairing of high-dose NAD+ supplementation (1000mg) and the novel GLP-1 receptor agonist, Retatrutide. This intriguing approach aims to address multiple facets of metabolic dysfunction , potentially offering